CDEK
← All organizations
Motus Therapeutics, Inc.

Motus Therapeutics, Inc.

For profitWebsite ↗

Also known as: Motus Melior | Motus Melior, Ltd.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Jul 1, 2011

Last known activity

Jun 1, 2015

Acquired by Allergan PLC (2015) → AbbVie on Oct 27, 2016

Timeline

2000s

  1. Jan 1, 2008

    Motus Therapeutics, Inc.— Founded

2010s

  1. Oct 27, 2016

    Allergan PLC (2015)— Acquired By

  2. Jun 26, 2019

    AbbVie— Now

Drugs by trial phase (1 distinct, 8 trials)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (8)

Details

Founded
Boston, MA, US Jan 1, 2008
Last known activity
Jun 1, 2015